2022
DOI: 10.1200/jco.2022.40.16_suppl.e13614
|View full text |Cite
|
Sign up to set email alerts
|

Impact of Conti ransomware attack on cancer trials Ireland sites.

Abstract: e13614 Background: Cancer trials in Ireland are conducted in both public Health Service Executive (HSE) and private hospitals and are overseen by Cancer Trials Ireland (CTI). On the 14th of May 2021 the Irish National HSE was the victim of a “Conti” ransomware attack. The attack triggered a “Critical Incident Process,” and the shutting down of all HSE IT systems at a national level. Disruption to patient care across the HSE’s 4000 locations, 54 acute hospitals, and 70,000 connected devices was drastic, immedi… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles